{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"}],"units":"Participants"}],"description":"Incidence of any grade 3 or higher adverse events using Common Terminology Criteria for Adverse Events (CTCAE). Number or patients reporting a grade 3 or higher adverse event according to CTCAE","groups":[{"description":"Patients receive placebo oral solution (swish, gargle for 30 seconds, and slowly swallow) on day 1.","id":"OG000","title":"Placebo"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"5 were accrued but only 3 provided data. Since only 1 patient was accrued \\& completed the study on 1 arm, patient confidentiality prevents the reporting of results per intervention. 2nd crossover was optional; none chose to crossover. The study results are only reported for the 1st study period (before crossover) \\& only for placebo intervention.","reportingStatus":"POSTED","timeFrame":"Up to 4 hours after treatment","title":"Incidence of Any Grade 3 or Higher Adverse Events Using Common Terminology Criteria for Adverse Events (CTCAE)","type":"SECONDARY","unitOfMeasure":"Participants"}